| SVP | selective vagotomy and pyloroplasty; small volume parenteral [infusion]; standing venous pressure; s... |
|---|---|
| IF | 1) Immuno-Fluorescence 2) Intrinsic Factor |
| ISA | 1) Intrinsic Sympathomimetic Activity 2) Industrial Standard Architecture... |
| CIT | citrate; combined intermittent therapy; conjugated-immunoglobulin technique; crossed intrinsic trans... |
| GIF | gastric intrinsic factor; growth hormone-inhibiting factor |
| intrinsic muscles of foot | Muscles fully contained (origin, belly, insertion) in the foot and toes. These muscles are arranged in four layers and all are innervated by the plantar branches of the tibial nerve. Although they may be capable of producing the actions described under their individual entries, as a group the primary function of the intrinsic muscles of the foot is to provide dynamic support of the longitudinal arch of the foot, resisting the forces which act momentarily to spread the arch during walking and running. (05 Mar 2000) |
|---|---|
| intrinsic pathway | <haematology> Initiation of blood clotting as a result of factors released from damaged tissue, as opposed to contact with a foreign surface (the intrinsic pathway). Tissue thromboplastin (Factor III) in conjunction with Factor VII proconvertin) will activate Factor X that, once activated, converts prothrombin to thrombin. (27 Jun 1999) |
| intrinsic proteins | Proteins that cannot be easily separated from a biomembrane. Synonym: intrinsic proteins. (05 Mar 2000) |
| intrinsic reflex | A reflex muscular contraction elicited by the application of a stimulus, usually stretching, to the muscle itself as opposed to a muscular contraction caused by an extrinsic stimulus, e.g., skin, as in the abdominal skin reflex's. (05 Mar 2000) |
| intrinsic sphincter | A thickening of the circular fibres of the muscular coat of an organ. (05 Mar 2000) |
| intrinsic sympathomimetic activity | The property of a drug that causes activation of adrenergic receptors so as to produce effects similar to stimulation of the sympathetic nervous system. (05 Mar 2000) |
| tonoplast intrinsic protein | <protein> Plant protein, closely related to major intrinsic protein. Found in plant storage vacuolar membranes. (18 Nov 1997) |
| autonomic nervous system | <anatomy> Neurons that are not under conscious control, comprising two antagonistic components, the sympathetic and parasympathetic nervous systems. The autonomic nervous system regulates key functions including the activity of the cardiac (heart) muscle, smooth muscles (e.g., of the gut), and glands. The autonomic nervous system has two divisions: 1. The sympathetic nervous system that accelerates the heart rate, constricts blood vessels, and raises blood pressure. 2. The parasympathetic nervous system slows the heart rate, increases intestinal and gland activity, and relaxes sphincter muscles. (03 Jul 1999) |
| autonomic nervous system diseases | Diseases that have their major effects on the autonomic nervous system. The autonomic nervous system may be seriously affected in many other disorders including other peripheral nervous system diseases, infectious diseases (e.g., tetanus, diphtheria), immunologic diseases (e.g., acquired immunodeficiency syndrome), and systemic disorders (e.g., diabetic neuropathy, amyloid neuropathy, thyroid diseases). Disorders of central autonomic control also contribute substantially to a wide variety of problems (e.g., eating disorders, panic disorder, water-electrolyte imbalance, cardiovascular diseases). (12 Dec 1998) |
| vegetative nervous system | <anatomy> Neurons that are not under conscious control, comprising two antagonistic components, the sympathetic and parasympathetic nervous systems. The autonomic nervous system regulates key functions including the activity of the cardiac (heart) muscle, smooth muscles (e.g., of the gut), and glands. The autonomic nervous system has two divisions: 1. The sympathetic nervous system that accelerates the heart rate, constricts blood vessels, and raises blood pressure. 2. The parasympathetic nervous system slows the heart rate, increases intestinal and gland activity, and relaxes sphincter muscles. (03 Jul 1999) |
| ventral nervous system defective | <molecular biology> A Drosophila gene encoding an integral membrane glycoprotein related to amyloidogenic glycoprotein. (12 Jan 1998) |
| parasympathetic nervous system | <anatomy, neurology> One of the two divisions of the vertebrate autonomic nervous sytem. Parasympathetic nerves emerge cranially as pre ganglionic fibres from oculomotor, facial, glossopharyngeal and vagus and from the sacral region of the spinal cord. most neurons are cholinergic and responses are mediated by muscarinic receptors. The parasympathetic system innervates, for example: salivary glands, thoracic and abdominal viscera, bladder and genitalia. Compare:. Sympathetic nervous system. (18 Nov 1997) |
| visceral nervous system | <anatomy> Neurons that are not under conscious control, comprising two antagonistic components, the sympathetic and parasympathetic nervous systems. The autonomic nervous system regulates key functions including the activity of the cardiac (heart) muscle, smooth muscles (e.g., of the gut), and glands. The autonomic nervous system has two divisions: 1. The sympathetic nervous system that accelerates the heart rate, constricts blood vessels, and raises blood pressure. 2. The parasympathetic nervous system slows the heart rate, increases intestinal and gland activity, and relaxes sphincter muscles. (03 Jul 1999) |
| central nervous system | <anatomy, neurology> Pertaining to the brain, cranial nerves and spinal cord. It does not include muscles or peripheral nerves. In invertebrates, the central nervous system is composed of the segmental ganglia of the ventral nerve cord together with the fused ganglia or brain at the anterior end. Acronym: CNS (12 Jan 1998) |
| central nervous system agents | A class of drugs producing both physiological and psychological effects through a variety of mechanisms. They can be divided into "specific" agents, e.g., affecting an identifiable molecular mechanism unique to target cells bearing receptors for that agent, and "non-specific" agents, those producing effects on different target cells and acting by diverse molecular mechanisms. Those with non-specific mechanisms are generally further classed according to whether they produce behavioural depression or stimulation. Those with specific mechanisms are classed by locus of action or specific therapeutic use. (12 Dec 1998) |